Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable for intravenous use. It treats severe bacterial infections such as intra‑abdominal, urinary tract, pulmonary, bloodstream and central nervous system infections in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare institutions. Meropenem Steriscience is manufactured under EU GMP guidelines, ensuring batch consistency and purity for critical care use.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious infections caused by Gram‑negative and Gram‑positive bacteria.

- Complicated intra‑abdominal infections: provides rapid bacterial clearance in polymicrobial abdominal sepsis. - Complicated urinary tract infections: eradicates resistant uropathogens, aiding resolution of pyelonephritis. - Hospital‑acquired pneumonia: penetrates lung tissue to treat multidrug‑resistant pneumonia. - Septicemia: achieves high plasma concentrations to control bloodstream infection. - Meningitis: crosses the blood‑brain barrier to treat bacterial meningitis.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption. - Headache: transient cranial discomfort. - Injection site reactions: pain or erythema at the infusion site. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Anaphylaxis: acute hypersensitivity reaction requiring emergency care. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Hepatic failure: rare but potentially life‑threatening liver dysfunction.

Meropenem should be used with caution in specific clinical situations.

- Renal function: adjust dose in patients with impaired clearance. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. - Pregnancy: prescribe only when benefits outweigh potential risks. - Concomitant valproic acid: monitor for reduced antiepileptic effect. - Superinfection: watch for secondary fungal or bacterial infections. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Valproic acid: may reduce antiepileptic efficacy, risking seizure breakthrough. - Aminoglycosides: additive nephrotoxicity when combined. - Other nephrotoxic agents: increased risk of renal impairment.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Loop diuretics: may affect renal clearance of meropenem. - Probenecid: can increase meropenem plasma concentrations, necessitating dose review.